Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel

Clinical trial NCT01891864 · COMPLETED

Trial details

NCT number: NCT01891864
Sponsor: Sandoz
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Stable Plaque Psoriasis

Start date: 2013-06-01
Primary completion: 2014-06-01
Enrollment: 531

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.